Global Thyroid Cancer Diagnostics Market Size & Outlook
Global thyroid cancer diagnostics market, 2016-2027 (US$M)
Related Markets
Global thyroid cancer diagnostics market highlights
- The global thyroid cancer diagnostics market generated a revenue of USD 2,506.0 million in 2019 and is expected to reach USD 3,849.5 million by 2027.
- The market is expected to grow at a CAGR (2020 - 2027) of 5.5% by 2027.
- In terms of segment, papillary carcinoma accounted for a revenue of USD 2,010.0 million in 2019.
- Follicular Carcinoma is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2019.
- Country-wise, U.S. is expected to register the highest CAGR from 2020 to 2027.
Global data book summary
| Market revenue in 2019 | USD 2,506.0 million |
| Market revenue in 2027 | USD 3,849.5 million |
| Growth rate | 5.5% (CAGR from 2019 to 2027) |
| Largest segment | Papillary carcinoma |
| Fastest growing segment | Follicular Carcinoma |
| Historical data covered | 2016 - 2018 |
| Base year for estimation | 2019 |
| Forecast period covered | 2020 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Papillary Carcinoma, Follicular Carcinoma |
Other key industry trends
- In terms of revenue, the North America accounted for 43.1% of the global thyroid cancer diagnostics market in 2019.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2027.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 1,350.8 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Thyroid Cancer Diagnostics Market Scope
Thyroid Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global thyroid cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thyroid cancer diagnostics market will help companies and investors design strategic landscapes.
Papillary carcinoma was the largest segment with a revenue share of 80.21% in 2019. Horizon Databook has segmented the Global thyroid cancer diagnostics market based on papillary carcinoma, follicular carcinoma covering the revenue growth of each sub-segment from 2016 to 2027.
- Global Thyroid Cancer Diagnostics Type Outlook (Revenue, USD Million, 2016-2027)
- Papillary Carcinoma
- Follicular Carcinoma
- Others
- Global Thyroid Cancer Diagnostics Technique Outlook (Revenue, USD Million, 2016-2027)
- Blood Test
- Imaging
- Biopsy
- Others
- Global Thyroid Cancer Diagnostics End Use Outlook (Revenue, USD Million, 2016-2027)
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
Reasons to subscribe to Global thyroid cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global thyroid cancer diagnostics market databook
-
Our clientele includes a mix of thyroid cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global thyroid cancer diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global thyroid cancer diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Global thyroid cancer diagnostics market size, by regions, 2016-2027 (US$M)
Top 10 countries: Thyroid cancer diagnostics market size, 2019 (US$M)
Global thyroid cancer diagnostics market share, by type, 2019 & 2027 (%, US$M)
Thyroid cancer diagnostics market: Opportunity assessment by country
Global thyroid cancer diagnostics market, by region, 2019 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
